Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
EULAR welcomes Daniel Aletaha as new EULAR President
EULAR—The European Alliance of Associations for Rheumatology—is pleased to announce a change in its presidency, as Professor Annamaria Iagnocco, Italy, has stepped down as President and handed over the role to Professor Daniel Aletaha, Austria.
Professor Aletaha will lead EULAR in its mission to improve the lives of people with rheumatic and musculoskeletal diseases (RMDs), build on EULAR’s successes and drive EULAR forward. He is committed to continuing the work of his predecessor and taking the organisation to even greater heights.
The full press release is available at EULAR press releases %7C EULAR
The latest recommendations from EULAR
Points to consider: EULAR–UEMS standards for the training of European rheumatologists https://ard.bmj.com/content/early/2023/05/15/ard-2023-223941
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update https://ard.bmj.com/content/early/2023/03/16/ard-2022-223764
For recommendations relevant to patient audiences, EULAR provides a lay summary version in English and calls on all interested organisations to disseminate them and encourage the translation into their own language:
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update https://www.eular.org/web/static/lib/pdfjs/web/viewer.html?file=https://www.eular.org/document/download/630/7267ef1d-6df8-46da-a4ff-3f7124f7d6a2/615
Find more EULAR Recommendations at EULAR %7C Recommendations and initiatives
EULAR has launched the Individual Membership — Blue Membership
EULAR Individual Membership provides an outstanding opportunity for us to unite and work towards a better future, improving the lives of people with rheumatic and musculoskeletal diseases (RMDs) while reducing the burden of RMDs on individuals and society. By becoming a member, you can access the EULAR App, get a discount on EULAR 2024 Congress tickets, apply for Committee involvement and more.
Learn more about it at Membership %7C EULAR
Thank you for another outstanding EULAR 2023 Congress experience
We hope all attendees had a wonderful experience, enjoyed the scientific programme and established valuable connections with other professionals in the field of Rheumatology! The EULAR 2023 Congress offered extraordinary on-site and online experience with 129 scientific sessions, more than 300 renowned speakers, over 4500 submitted abstracts and nearly 12 400 on-site delegates.
EULAR 2023 is available online on-demand until 31 December
The complete Scientific Programme is available online on-demand until 31 December to all registered participants. Access to basic, clinical and translational research, education and many more comprehensive topics in rheumatology.
The registration deadline for on-demand access is 31 July 2023 EULAR 2023 – Registration
From the North of Italy to the East of Austria — EULAR 2024 Congress in Vienna
Save the date and visit us at the next EULAR European Congress of Rheumatology in Vienna, on 12–15 June 2024.
The new timeline for EULAR 2024 is available EULAR 2024 Timeline
With the next European Parliament and new Commission term beginning in 2024, EULAR has started working on a EULAR Manifesto to present to policymakers. These recommendations, aimed at improving the conditions of European rheumatology, are achievable by the European Union (EU) and its Member States. The main document is intended to serve as an easily understandable summary of EULAR’s policy tasks in the areas of quality of care, social policy and research. The EULAR Manifesto will be accompanied by a data and research-driven background document on why RMDs should be properly recognised by and addressed in the EU’s healthcare and social policies.
EULAR launches first European patient-filled survey about the impact of RMDs
The EULAR Impact of RMDs Survey is an online questionnaire targeted directly at patients with RMDs. The survey will collect first-hand, longitudinal information about the impact of RMDs on the lives of patients across Europe. EULAR encourages all patients to participate by sharing relevant information and insights into their lives with an RMD. For more information on how to take part, please visit the website: EULAR Impact of RMDs Survey
EULAR develops a European Network of Clinical Trial Centres
The EULAR Network of Trial Centres (ENTRI) is an initiative by the EULAR Research Centre, dedicated to facilitating RMD-related clinical trial delivery for patient benefit across and beyond Europe. By collaborating with Contract Research Organisations (CROs), healthcare professionals and patients, pharmaceutical companies, EULAR aims to create a database of potential clinical centres across EULAR-affiliated countries. If you would like to know more, visit our website: EULAR ENTRI
EULAR School of Rheumatology—registration to online courses now open
EULAR School of Rheumatology—4th EULAR Postgraduate Course for HPR
This course focuses on knowledge and skills most relevant for Health Professionals in Rheumatology (HPR)s’ daily practice. The course takes place from Friday, 29 September 2023 to Saturday, 30 September 2023. Participants have the opportunity to meet experts in an informal setting and network with other HPR with different professional backgrounds. Course: 4th EULAR Postgraduate Course Health Professionals in Rheumatology 2023
Patient consent for publication
Handling editor Josef S Smolen
Contributors Yuliia Caliskan was responsible for creating and editing content. Julia Rautenstrauch was responsible for editing and the overall content as guarantor.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.